The divine mysteries of AI

Sharing here a thoughtful analysis on Artificial Intelligence written by Stephen Marche. “…But the sorcery of artificial intelligence is different. When you develop a drug, or a new material, you may not understand exactly how it works, but you can isolate what substances you are dealing with, and you can test their effects. …Technology is moving…

2022 CONNECTIVITY AND DIGITAL TRENDS – MANAGING HEALTH

TO UNDERSTAND CONSUMER attitude toward digital life, Deloitte’s Center for Technology, Media & Telecommunications conducted a survey of 2,005 US consumers in Q1 2022. Aspects of digital life that they surveyed include devices (technology, entertainment, smart home, smartphones), connectivity (home internet and mobile), virtual experiences (work, school, and health care), wearables (fitness trackers and smart…

Digitalising pharma R&D

R&D digital transformation is essential to remain competitive in the near future. There will come the time when more patients than the systems can handle. The COVID19 dilemma will become a daily struggle. Digitisation – and digitalisation – are not something companies can debate on. It isn’t about building a competitive advantage or a core…

The “Blood, toil, tears, sweat” of the healthcare sector

At this very moment, pharmaceutical companies and biotech startups from San Francisco and Boston to Tianjin, Tokyo and Galilee, are staging a multi-front battle against the novel coronavirus akin to the sea, land and air assault conducted by the allies against Nazi Germany on D-Day during World War II. Last September, Gallup released an opinion…

Die Covid-19-Krise und der Sechs-Punkte-Plan

Schlacht mit Bazookas: das ist was die Schweizer Wirtschaft braucht, um die Covid-19 Krise zu überwinden und die wirtschaftliche Situation bald zu beleben. “Ein Paket, das 30 Prozent des Schweizer BIP (oder etwa 200 Milliarden Franken) binden würde, dürfte in der Lage sein, unsere Wirtschaft in den nächsten Monaten zu finanzieren, die Nachfrage wieder zu beleben…